These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux. Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475 [TBL] [Abstract][Full Text] [Related]
3. Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM. Taskinen MR; Packard CJ; Shepherd J Diabetes; 1990 Sep; 39(9):1017-27. PubMed ID: 2200727 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. Packard CJ; Demant T; Stewart JP; Bedford D; Caslake MJ; Schwertfeger G; Bedynek A; Shepherd J; Seidel D J Lipid Res; 2000 Feb; 41(2):305-18. PubMed ID: 10681415 [TBL] [Abstract][Full Text] [Related]
5. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans. Anber V; Millar JS; McConnell M; Shepherd J; Packard CJ Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2507-14. PubMed ID: 9409221 [TBL] [Abstract][Full Text] [Related]
6. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans. Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893 [TBL] [Abstract][Full Text] [Related]
7. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease. Quaschning T; Krane V; Metzger T; Wanner C Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S14-9. PubMed ID: 11576915 [TBL] [Abstract][Full Text] [Related]
8. Hypertriglyceridemia: lipoprotein receptors and atherosclerosis. Gianturco SH; Gotto AM; Bradley WA Adv Exp Med Biol; 1985; 183():47-71. PubMed ID: 4036704 [TBL] [Abstract][Full Text] [Related]
9. Metabolism of apoB-100 in lipoproteins separated by density gradient ultracentrifugation in normal and Watanabe heritable hyperlipidemic rabbits. Shames DM; Yamada N; Havel RJ J Lipid Res; 1990 May; 31(5):753-62. PubMed ID: 2380627 [TBL] [Abstract][Full Text] [Related]
10. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates. Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202 [TBL] [Abstract][Full Text] [Related]
16. Atherogenicity of triglyceride-rich lipoproteins. Krauss RM Am J Cardiol; 1998 Feb; 81(4A):13B-17B. PubMed ID: 9526808 [TBL] [Abstract][Full Text] [Related]
17. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome. Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523 [TBL] [Abstract][Full Text] [Related]
18. Lipoprotein kinetics in patients with analbuminemia. Evidence for the role of serum albumin in controlling lipoprotein metabolism. Maugeais C; Braschi S; Ouguerram K; Maugeais P; Mahot P; Jacotot B; Darmaun D; Magot T; Krempf M Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1369-75. PubMed ID: 9261269 [TBL] [Abstract][Full Text] [Related]
20. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. Teng B; Sniderman AD; Soutar AK; Thompson GR J Clin Invest; 1986 Mar; 77(3):663-72. PubMed ID: 3949973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]